Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications.
about
Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord InjuryRegenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem CellsMesenchymal stromal cells in the development and therapy of bronchopulmonary dysplasiaStem Cells and Their Mediators - Next Generation Therapy for Bronchopulmonary DysplasiaMesenchymal stromal cell-based therapy: Regulatory and translational aspects in gastroenterologyRecent Developments in Cellular Immunotherapy for HSCT-Associated ComplicationsWharton's Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host DiseaseConcise Review: Mesenchymal Stem Cell Therapy for Pediatric Disease: Perspectives on Success and Potential Improvements.Diverging Concepts and Novel Perspectives in Regenerative Medicine.Optimization of in vitro cultivation strategies for human adipocyte derived stem cellsManufacturing of dental pulp cell-based products from human third molars: current strategies and future investigations.Massive Clonal Selection and Transiently Contributing Clones During Expansion of Mesenchymal Stem Cell Cultures Revealed by Lentiviral RGB-Barcode Technology.Detection of mesenchymal stem cells senescence by prelamin A accumulation at the nuclear level.Epigenetic Classification of Human Mesenchymal Stromal Cells.Remestemcel-L for the treatment of graft versus host disease.Quality Control Assays for Clinical-Grade Human Mesenchymal Stromal Cells: Methods for ATMP Release.Fibroblast Growth Factor 2 Regulates High Mobility Group A2 Expression in Human Bone Marrow-Derived Mesenchymal Stem CellsExpansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier processProspect of stem cell conditioned medium in regenerative medicine.Immunosuppressive capacity of mesenchymal stem cells correlates with metabolic activity and can be enhanced by valproic acid.Decoy TRAIL receptor CD264: a cell surface marker of cellular aging for human bone marrow-derived mesenchymal stem cellsThe IDO inhibitor 1-methyl tryptophan activates the aryl hydrocarbon receptor response in mesenchymal stromal cells.Effective tracking of bone mesenchymal stem cells in vivo by magnetic resonance imaging using melanin-based gadolinium3+ nanoparticles.Automated image analysis detects aging in clinical-grade mesenchymal stromal cell cultures.Cryopreservation and Banking of Dental Stem Cells.Allogeneic cell therapy bioprocess economics and optimization: downstream processing decisions.Immunomodulatory effects of mesenchymal stromal cells-derived exosome.Autologous Mesenchymal Stromal Cells Prevent Transfusion-elicited Sensitization and Upregulate Transitional and Regulatory B CellsMesenchymal Stromal Cells: From Discovery to Manufacturing and Commercialization
P2860
Q26748907-6790A9DE-8F4B-4FA0-B19F-326EFAFF4C81Q26752205-D01B3566-EABC-4505-AA9F-26151C295696Q26753057-95FED285-F2D7-4DD6-968E-C04209FF8F84Q26797261-89C09B27-706B-494A-960A-B28E4D716C9EQ28077427-8D1F4C3E-C81F-4311-8BD1-29BDC6030E54Q28079823-79C37385-04ED-4F5A-9446-85DDE063FF35Q28083027-88AD8D32-4D2C-4173-A194-155DA4DE2A21Q33722466-D893BFB5-8B7E-4ABA-8DF1-ECB32CD1144DQ33755185-64DDED2A-5293-4323-98D1-24C025A327E3Q35834750-AF6BC44D-9C37-4632-8C97-6F03335AC500Q35921981-C6E5E9BB-478E-4CC5-8729-0CB8745DEB14Q36808567-8E68217C-EDAF-47CC-9927-1613F94643DAQ37211621-5D70F542-361E-4E3C-B954-B7B41C95F885Q38365126-956B99B5-A05C-4435-AF34-57CB0F772BB6Q38892351-852B285D-7ECA-47B8-994F-D7905E6A87E0Q39728173-AA1235C6-F5EB-46D8-9C33-1931B4BF6D1BQ40961662-3C7F18CE-0F70-4FA9-BBB3-0447F45990E1Q41132806-FF9F8F1E-3171-44A2-B920-0AB72AE88DD6Q41660528-153963B4-BC4F-42D9-A5C0-C2D7745FA7EAQ42152726-9F79E2AC-C59E-49FE-A99B-636A42F981CCQ42368059-F7723D52-E5C2-494C-ADCE-B72C690DD31DQ45276957-F288ACC5-F777-43C8-834D-731F757479BEQ46114524-9AC4DF37-D084-4453-B920-911C740564D5Q48268677-31617EDB-3CCB-44B8-82D6-6E00CC9FB20DQ51101729-679861A9-D89F-4B30-A5F8-3A513B9A4D45Q51823214-D89EAEA4-3EBB-4755-9FB4-E5E82EA14B72Q53989481-C3976A95-B7BD-47C9-A0BF-D566AAE6BBD3Q58700304-61344CB5-535A-4233-A0A5-2B0D197EAB56Q58855503-4B8DAB09-EC5D-4F1B-9F65-63004D955BA5
P2860
Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Standardization of Good Manufa ...... mmunotherapeutic applications.
@ast
Standardization of Good Manufa ...... mmunotherapeutic applications.
@en
type
label
Standardization of Good Manufa ...... mmunotherapeutic applications.
@ast
Standardization of Good Manufa ...... mmunotherapeutic applications.
@en
prefLabel
Standardization of Good Manufa ...... mmunotherapeutic applications.
@ast
Standardization of Good Manufa ...... mmunotherapeutic applications.
@en
P2093
P50
P1433
P1476
Standardization of Good Manufa ...... mmunotherapeutic applications.
@en
P2093
Anita Schmitt
Anthony D Ho
Eike C Buss
Georg Malcherek
Hubert Schrezenmeier
Karen Bieback
Lutz P Müller
Matthias Renner
Michael Schmitt
Patrick Horn
P304
P356
10.1016/J.JCYT.2014.04.002
P577
2014-05-20T00:00:00Z